HOME >> BIOLOGY >> NEWS
UCF brain cell research spawns hope for longer life

stents and other devices that are prone to inflammatory reactions.

Initial tests show that the nanoparticle anti-oxidants regenerate once they penetrate the cell -- meaning one dose could conceivably continue its therapeutic effects indefinitely.

Rzigalinski introduced the collaboration to her colleagues at the NATURE biotechnology symposium in Miami earlier this year. She has also submitted an abstract on the project to the National and International Neurotrauma Symposium, and Society for Neuroscience.

Nanotechnology is considered the new frontier of science, and it could revolutionize modern medicine in the future. The potential for creating new materials at a size capable of being absorbed by human cells calls for a new type of scientist -- one who can collaborate across seemingly unrelated disciplines. Combining the fields of biomolecular science with engineering offers a significant step in that direction.

Pappachan Kolattukudy, director of UCF's Biomolecular Science Center and a consultant on the project, said the collaboration is part of a strategy that UCF is going to be using increasingly in building its presence in the biomolecular sciences.

"We are concentrating on building interfaces between areas in which we have strengths," Kolattukudy said.

Vimal Desai, director of AMPAC, said that nanomaterials are currently considered highly strategic for important applications ranging from homeland security to just plain good health.

"It is so good to be able to build bridges for an interdisciplinary effort through competent and dynamic researchers at UCF," Desai said.


'"/>

Contact: Barb Abney
bcompton@mail.ucf.edu
407-823-5139
University of Central Florida
13-Aug-2003


Page: 1 2 3

Related biology news :

1. Trial shows which brain cancer patients benefit from temozolomide
2. Targeted therapy knocks out pediatric brain cancer in mice
3. New way to protect brain from stroke damage
4. Chemical signals health of brain cells Symposium
5. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
6. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
7. Genetic clues found for common congenital brain disorder
8. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
9. Molecular therapeutics advance fight against brain cancer
10. Depression traced to overactive brain circuit
11. Clusters of alterations on PIK3CA gene found in brain cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... priced an offering of €500.0 million principal amount of its ... amount of its 2.425% senior unsecured notes due 2026. ... occur on December 13, 2016, subject to the satisfaction of customary ... basis. The Company intends to ...
(Date:12/2/2016)...   SoftServe , a global digital technology ... electrocardiogram (ECG) biosensor analysis system for continuous driver ... The smart system ensures device-to-device communication between ECG ... mobile devices to easily ,recognize, and monitor users ... technology advances, so too must the security systems ...
(Date:11/29/2016)... , November 29, 2016 Nearly one billion matches ... Reading ... DERMALOG ... of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... Opal ... provide essential device-to-computer interconnect using USB or PCI Express, announced the FOMD-ACV-A4, the ... FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard 204-pin SODIMM ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This single ... engineered to radically streamline culture processes, minimize processing time, significantly decrease production ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. ... discovers, develops and plans to commercialize innovative therapeutics ... of common stock were approved for trading on ... trading on the OTCQX, effective today, under the ... the OTCQX market, companies must meet high financial ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology:
Cached News: